Chiara Russo


Cantor Comments on Flexion Therapeutics Inc (FLXN) In Light of Buyout Rumors

Flexion Therapeutics Inc (NASDAQ:FLXN) shares are on the rise today on the back of rumors that Sanofi (NYSE:SNY) is in talks to acquire …

Cantor Analyst Chimes In on Amarin Corporation plc (ADR) (AMRN) Following Corporate Update

In a research report published Tuesday, Cantor analyst Chiara Russo reiterated an Overweight rating on shares of Amarin Corporation plc (ADR) (NASDAQ:AMRN), with …

Here’s Why Agile Therapeutics Inc (AGRX) Shares Are Crashing 49% Today; Cantor Remains Bullish

Agile Therapeutics Inc (NASDAQ:AGRX) investors are in a scramble today after the firm released top-line data from its SECURE Phase 3 study of …

Here’s Why Cantor Bullish on Cidara Therapeutics Inc (CDTX); Shares Rise 7%

Cantor analyst Chiara Russo is sharing some positive perspective on Cidara Therapeutics Inc (NASDAQ:CDTX) after the firm announced this morning the enrollment is …

Cantor Sees CAPB Advantage for Paratek Pharmaceuticals Inc (PRTK) in Wake of Cempra Inc (CEMP) CRL Setback

Cantor analyst Chiara Russo is liking the odds for Paratek Pharmaceuticals Inc (NASDAQ:PRTK) after Cempra Inc (NASDAQ:CEMP) received a Complete Response Letter (CRL) …

Here’s Why Cantor Cheers Egalet Corp (EGLT); Shares Climb 13%

Egalet Corp (NASDAQ:EGLT) shares were sent on a close to 13% rise today after the firm announced this morning that its pipeline drug Egalet-002, …

Cantor Initiates Coverage on Amarin Corporation plc (ADR) (AMRN); Sees 86% Upside for the Stock

In a research report, Cantor analyst Chiara Russo initiates coverage on shares of Amarin Corporation plc (ADR) (NASDAQ:AMRN) with a Buy rating and …

Cantor Comments on Heron Therapeutics Inc (HRTX) As It Won FDA Approval

In a research report published Wednesday, Cantor analyst Chiara Russo reiterated a Buy rating on shares of Heron Therapeutics Inc (NASDAQ:HRTX) with a price …

Here’s Why Cantor Reiterates Buy on Tonix Pharmaceuticals Holding Corp. (TNXP)

Late this past Friday, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) came in with numbers for its second quarter, posting a loss of ($0.

Cantor Chimes In On Heron Therapeutics Inc (HRTX) Following Phase 2 Clinical Success

Heron Therapeutics Inc (NASDAQ:HRTX) has found Phase 2 success with its lead product candidates for the prevention of post-operative pain, HTX-011 and HTX-011B. …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts